Charles Schwab Investment Management »

Armata Pharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Armata Pharmaceuticals (ARMP) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Armata Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Armata Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Armata Pharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $187k 29k 6.48

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Armata Pharmaceuticals

Madison Asset Management
BlackRock
Vanguard Capital Management
Millennium Management
Geode Capital Management
Dauntless Investment Group
Northern Trust
Vanguard Portfolio Management
Edgewood Management
Vanguard Fiduciary Trust
State Street Corporation
GSB Wealth Management
Renaissance Technologies
Bridgeway Capital Management
SeaCrest Wealth Management

View all funds holding Armata Pharmaceuticals